Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma
- 30 March 2012
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 29 (4) , 2800-2808
Abstract
C-reactive protein (CRP) is known to be associated with poor prognosis in patients with various malignancies. We investigated the relationship between the pretreatment serum CRP level and survival in patients with hepatocellular carcinoma (HCC) in various stages of the disease. A cohort of 133 patients with newly diagnosed HCC was prospectively evaluated. The patients were divided into two groups: high-CRP group (n = 27) with the pretreatment serum CRP level ≧ 1.0 mg/dl and low-CRP group (n = 106) with the CRP level < 1.0 mg/dl. They were followed 22 months in average (1–69 months) and clinicopathological variables, and overall survivals between the two groups were compared at the end of the follow-up period. There was a significant difference between the two groups in aspartate aminotransferase, alanine aminotransferase, total serum bilirubin, albumin, α-fetoprotein level, maximal tumor diameter, frequency of vascular invasion and extrahepatic metastases. Patients in the high-CRP group had higher Child-Pugh scores, higher Cancer of the Liver Italian Program scores and higher Japan Integrated Staging scores than patients in the low-CRP group. The overall survival rates in the high-CRP group were significantly lower than those in the low-CRP group. Survival rates were similar in tumor stage and liver function-matched patients. On multivariate analysis, pretreatment serum CRP level was independently associated with overall survival. Our results demonstrate that the pretreatment serum CRP level is associated with tumor progression and reduced liver function and is an independent poor prognostic marker in patients with HCC.Keywords
This publication has 28 references indexed in Scilit:
- Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinomaJournal of Surgical Oncology, 2010
- C-reactive protein in liver cancer surgeryEuropean Journal of Surgical Oncology, 2008
- Serum C‐reactive protein levels predict survival in hepatocellular carcinomaLiver International, 2007
- A systematic review of the association between circulating concentrations of C reactive protein and cancerJournal of Epidemiology and Community Health, 2007
- Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip ScoreHepatology, 2004
- Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus.2004
- Systemic inflammatory response predicts survival following curative resection of colorectal cancerBritish Journal of Surgery, 2003
- Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinomaThe American Journal of Surgery, 2001
- Plasma protein profiles and prognosis in gastric cancerBritish Journal of Cancer, 1982
- Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsiesCancer, 1954